Point-of-Care Molecular Diagnostics Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Point-of-Care Molecular Diagnostics Market, By Technology

7.1.  Point-of-Care Molecular Diagnostics Market, By Technology, 2020-2028

7.1.1.    PCR-based

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Genetic Sequencing-based

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Hybridization-based

7.1.3.1.        Market Revenue and Forecast (2016-2028)

7.1.4.    Microarray-based

7.1.4.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Point-of-Care Molecular Diagnostics Market, By Application

8.1.  Point-of-Care Molecular Diagnostics Market, by Application, 2020-2028

8.1.1.    Infectious Diseases

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Oncology

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Hematology

8.1.3.1.        Market Revenue and Forecast (2016-2028)

8.1.4.    Prenatal Testing

8.1.4.1.        Market Revenue and Forecast (2016-2028)

8.1.5.    Endocrinology

8.1.5.1.        Market Revenue and Forecast (2016-2028)

8.1.6.    Other Applications

8.1.6.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Point-of-Care Molecular Diagnostics Market, Test Location

9.1.  Point-of-Care Molecular Diagnostics Market, Test Location, 2020-2028

9.1.1.    Over-the-Counter (OTC)

9.1.1.1.        Market Revenue and Forecast (2016-2028)

9.1.2.    PoC

9.1.2.1.        Market Revenue and Forecast (2016-2028)

Chapter 10.      Global Point-of-Care Molecular Diagnostics Market, End Use

10.1.        Point-of-Care Molecular Diagnostics Market, End Use, 2020-2028

10.1.1.  Decentralized Labs

10.1.1.1.      Market Revenue and Forecast (2016-2028)

10.1.2.  Hospitals

10.1.2.1.      Market Revenue and Forecast (2016-2028)

10.1.3.  Homecare

10.1.3.1.      Market Revenue and Forecast (2016-2028)

10.1.4.  Assisted Living Healthcare Facilities

10.1.4.1.      Market Revenue and Forecast (2016-2028)

10.1.5.  Other Uses

10.1.5.1.      Market Revenue and Forecast (2016-2028)

Chapter 11.      Global Point-of-Care Molecular Diagnostics Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.1.2.  Market Revenue and Forecast, by Application (2016-2028)

11.1.3.  Market Revenue and Forecast, Test Location (2016-2028)

11.1.4.  Market Revenue and Forecast, End Use (2016-2028)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.1.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.1.5.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.1.5.4.      Market Revenue and Forecast, End Use (2016-2028)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.1.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.1.6.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.1.6.4.      Market Revenue and Forecast, End Use (2016-2028)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.2.2.  Market Revenue and Forecast, by Application (2016-2028)

11.2.3.  Market Revenue and Forecast, Test Location (2016-2028)

11.2.4.  Market Revenue and Forecast, End Use (2016-2028)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.5.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.2.5.4.      Market Revenue and Forecast, End Use (2016-2028)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.6.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.2.6.4.      Market Revenue and Forecast, End Use (2016-2028)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.7.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.7.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.2.7.4.      Market Revenue and Forecast, End Use (2016-2028)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.2.8.2.      Market Revenue and Forecast, by Application (2016-2028)

11.2.8.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.2.8.4.      Market Revenue and Forecast, End Use (2016-2028)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.3.2.  Market Revenue and Forecast, by Application (2016-2028)

11.3.3.  Market Revenue and Forecast, Test Location (2016-2028)

11.3.4.  Market Revenue and Forecast, End Use (2016-2028)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.5.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.3.5.4.      Market Revenue and Forecast, End Use (2016-2028)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.6.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.3.6.4.      Market Revenue and Forecast, End Use (2016-2028)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.7.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.7.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.3.7.4.      Market Revenue and Forecast, End Use (2016-2028)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.3.8.2.      Market Revenue and Forecast, by Application (2016-2028)

11.3.8.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.3.8.4.      Market Revenue and Forecast, End Use (2016-2028)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.4.2.  Market Revenue and Forecast, by Application (2016-2028)

11.4.3.  Market Revenue and Forecast, Test Location (2016-2028)

11.4.4.  Market Revenue and Forecast, End Use (2016-2028)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.5.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.4.5.4.      Market Revenue and Forecast, End Use (2016-2028)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.6.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.4.6.4.      Market Revenue and Forecast, End Use (2016-2028)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.7.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.7.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.4.7.4.      Market Revenue and Forecast, End Use (2016-2028)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.4.8.2.      Market Revenue and Forecast, by Application (2016-2028)

11.4.8.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.4.8.4.      Market Revenue and Forecast, End Use (2016-2028)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, By Technology (2016-2028)

11.5.2.  Market Revenue and Forecast, by Application (2016-2028)

11.5.3.  Market Revenue and Forecast, Test Location (2016-2028)

11.5.4.  Market Revenue and Forecast, End Use (2016-2028)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.5.5.2.      Market Revenue and Forecast, by Application (2016-2028)

11.5.5.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.5.5.4.      Market Revenue and Forecast, End Use (2016-2028)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, By Technology (2016-2028)

11.5.6.2.      Market Revenue and Forecast, by Application (2016-2028)

11.5.6.3.      Market Revenue and Forecast, Test Location (2016-2028)

11.5.6.4.      Market Revenue and Forecast, End Use (2016-2028)

Chapter 12.  Company Profiles

12.1.              Abbott Laboratories

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Bayer Healthcare

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              F. Hoffmann-La Roche AG

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Becton

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Dickinson and Company

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              BioMerieux

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Bio-Rad Laboratories, Inc.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Cepheid, Inc.

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Danaher Corporation

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Johnson and Johnson

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms